Cargando…

Biosynthesis of cannabigerol and cannabigerolic acid: the gateways to further cannabinoid production

Cannabinoids are a therapeutically valuable class of secondary metabolites with a vast number of substituents. The native cannabinoid biosynthetic pathway of Cannabis sativa generates cannabigerolic acid (CBGA), the common substrate to multiple cannabinoid synthases. The bioactive decarboxylated ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kearsey, Lewis J, Yan, Cunyu, Prandi, Nicole, Toogood, Helen S, Takano, Eriko, Scrutton, Nigel S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263468/ https://www.ncbi.nlm.nih.gov/pubmed/37323510 http://dx.doi.org/10.1093/synbio/ysad010

Ejemplares similares

Structure of the Cannabis sativa olivetol‐producing enzyme reveals cyclization plasticity in type III polyketide synthases
por: Kearsey, Lewis J., et al.
Publicado: (2019)

The Origin and Biomedical Relevance of Cannabigerol
por: Jastrząb, Anna, et al.
Publicado: (2022)

In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
por: Gugliandolo, Agnese, et al.
Publicado: (2018)

Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
por: Mammana, Santa, et al.
Publicado: (2019)

Anti-Biofilm Activity of Cannabigerol against Streptococcus mutans
por: Aqawi, Muna, et al.
Publicado: (2021)

Anti-Bacterial Properties of Cannabigerol Toward Streptococcus mutans
por: Aqawi, Muna, et al.
Publicado: (2021)

Acute Cannabigerol Administration Lowers Blood Pressure in Mice
por: Vernail, Victoria L., et al.
Publicado: (2022)

Cannabigerol Prevents Quorum Sensing and Biofilm Formation of Vibrio harveyi
por: Aqawi, Muna, et al.
Publicado: (2020)

Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives
por: Calapai, Fabrizio, et al.
Publicado: (2022)

Chronic Cannabigerol as an Effective Therapeutic for Cisplatin-Induced Neuropathic Pain
por: Nachnani, Rahul, et al.
Publicado: (2023)

Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018)

Chemotherapy‐induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol
por: Brierley, Daniel I., et al.
Publicado: (2019)

Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota
por: Luz-Veiga, Mariana, et al.
Publicado: (2023)

Mannich-type modifications of (−)-cannabidiol and (−)-cannabigerol leading to new, bioactive derivatives
por: Lőrincz, Eszter Boglárka, et al.
Publicado: (2023)

In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties
por: Perez, Eduardo, et al.
Publicado: (2022)

Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood–Brain Barrier Under Ischemic Conditions
por: Stone, Nicole L., et al.
Publicado: (2021)

Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats
por: Brierley, Daniel I, et al.
Publicado: (2016)

Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
por: Lah, Tamara T., et al.
Publicado: (2021)

Cannabidiol and Cannabigerol Modify the Composition and Physicochemical Properties of Keratinocyte Membranes Exposed to UVA
por: Wroński, Adam, et al.
Publicado: (2023)

SNP in Potentially Defunct Tetrahydrocannabinolic Acid Synthase Is a Marker for Cannabigerolic Acid Dominance in Cannabis sativa L.
por: Garfinkel, Andrea R., et al.
Publicado: (2021)

Cannabigerol Effect on Streptococcus mutans Biofilms—A Computational Approach to Confocal Image Analysis
por: Aqawi, Muna, et al.
Publicado: (2022)

Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways
por: Viereckl, Michael J., et al.
Publicado: (2022)

Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol
por: Ghovanloo, Mohammad-Reza, et al.
Publicado: (2022)

Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo
por: Fleisher-Berkovich, Sigal, et al.
Publicado: (2023)

Differences in the phospholipid profile of melanocytes and melanoma cells irradiated with UVA and treated with cannabigerol and cannabidiol
por: Łuczaj, Wojciech, et al.
Publicado: (2023)

Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy
por: Anderson, Lyndsey L., et al.
Publicado: (2021)

A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
por: Carrillo-Salinas, Francisco J., et al.
Publicado: (2014)

The Antibacterial Effect of Cannabigerol toward Streptococcus mutans Is Influenced by the Autoinducers 21-CSP and AI-2
por: Aqawi, Muna, et al.
Publicado: (2023)

Cannabigerol Activates Cytoskeletal Remodeling via Wnt/PCP in NSC-34: An In Vitro Transcriptional Study
por: Anchesi, Ivan, et al.
Publicado: (2023)

Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor
por: Aljobaily, Nouf, et al.
Publicado: (2022)

Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes
por: di Giacomo, Viviana, et al.
Publicado: (2020)

Neuroprotective and Neuromodulatory Effects Induced by Cannabidiol and Cannabigerol in Rat Hypo-E22 cells and Isolated Hypothalamus
por: di Giacomo, Viviana, et al.
Publicado: (2020)

In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA)
por: Pinzi, Luca, et al.
Publicado: (2019)

Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression
por: Wyrobnik, Iris, et al.
Publicado: (2023)

The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling
por: Lah, Tamara T., et al.
Publicado: (2022)

Concentration-Dependent Attenuation of Pro-Fibrotic Responses after Cannabigerol Exposure in Primary Rat Hepatocytes Cultured in Palmitate and Fructose Media
por: Sztolsztener, Klaudia, et al.
Publicado: (2023)

A ‘Plug and Play’ Platform for the Production of Diverse Monoterpene Hydrocarbon Scaffolds in Escherichia coli
por: Leferink, Nicole G. H., et al.
Publicado: (2016)

Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration
por: Aguareles, José, et al.
Publicado: (2019)

The Transcriptomic Analysis of NSC-34 Motor Neuron-Like Cells Reveals That Cannabigerol Influences Synaptic Pathways: A Comparative Study with Cannabidiol
por: Gugliandolo, Agnese, et al.
Publicado: (2020)

Will Cannabigerol Trigger Neuroregeneration after a Spinal Cord Injury? An In Vitro Answer from NSC-34 Scratch-Injured Cells Transcriptome
por: Valeri, Andrea, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nadvihrf3sgfdpehdjvh4racml